These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
630 related articles for article (PubMed ID: 31461811)
21. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377 [TBL] [Abstract][Full Text] [Related]
22. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts. Lunghi P; Tabilio A; Dall'Aglio PP; Ridolo E; Carlo-Stella C; Pelicci PG; Bonati A Leukemia; 2003 Sep; 17(9):1783-93. PubMed ID: 12970778 [TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. Kandil E; Tsumagari K; Ma J; Abd Elmageed ZY; Li X; Slakey D; Mondal D; Abdel-Mageed AB J Surg Res; 2013 Oct; 184(2):898-906. PubMed ID: 23602735 [TBL] [Abstract][Full Text] [Related]
24. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A; Agarwal R; Agarwal C Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755 [TBL] [Abstract][Full Text] [Related]
25. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744 [TBL] [Abstract][Full Text] [Related]
26. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Miranda MB; McGuire TF; Johnson DE Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350 [TBL] [Abstract][Full Text] [Related]
27. Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma. Mao JD; Wu P; Huang JX; Wu J; Yang G World J Gastroenterol; 2014 Sep; 20(35):12542-50. PubMed ID: 25253956 [TBL] [Abstract][Full Text] [Related]
28. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750 [TBL] [Abstract][Full Text] [Related]
29. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
30. [Effects of dihydroartiminisin on proliferation and phosphorylation of mitogen-activated protein kinase in epithelial ovarian cancer cell lines]. Tan XJ; Plouet J; Lang JH; Wu M; Shen K Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):662-5. PubMed ID: 19087515 [TBL] [Abstract][Full Text] [Related]
31. Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway. Fan W; Sun L; Zhou JQ; Zhang C; Qin S; Tang Y; Liu Y; Lin SS; Yuan ST Chin J Nat Med; 2015 Jun; 13(6):428-37. PubMed ID: 26073339 [TBL] [Abstract][Full Text] [Related]
32. [Effect of extracellular signal regulated kinase signal pathway on apoptosis induced by MG262 in ovarian cancer cells]. Wang WX; Kong BH; Li P; Song K; Qu X; Cui BX; Jiang J; Zhang YZ; Yang XS Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):690-4. PubMed ID: 19087521 [TBL] [Abstract][Full Text] [Related]
33. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926 [TBL] [Abstract][Full Text] [Related]
34. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
35. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713 [TBL] [Abstract][Full Text] [Related]
36. Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells. Wei SQ; Sui LH; Zheng JH; Zhang GM; Kao YL Chin Med Sci J; 2004 Jun; 19(2):125-9. PubMed ID: 15250250 [TBL] [Abstract][Full Text] [Related]
37. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101. Yazlovitskaya EM; Pelling JC; Persons DL Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740 [TBL] [Abstract][Full Text] [Related]
38. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways. Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244 [TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer]. Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477 [No Abstract] [Full Text] [Related]
40. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Su CC Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]